Unusual Case of Systemic Lupus Erythematosus (SLE) With Middle-Age Onset and Atypical Multisystem Involvement Middle-Age Onset SLE With Multisystem Involvement

Main Article Content

Yahya Ur Rehman
Tanvi Yadav
Priya Yadav
Sruthy Sasikumar

Abstract

Background: Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disorder predominantly affecting young females, with middle-age onset in males being a rare occurrence. Late-onset SLE can present with atypical multisystem involvement, complicating diagnosis and management.
Objective: To report an unusual case of SLE in a middle-aged male with multisystem complications, including lupus nephritis and pulmonary hypertension.
Methods: A 52-year-old male with dyspnea, chest pain, and lower extremity edema underwent comprehensive clinical evaluation. Laboratory tests included complete blood count, renal function tests, 24-hour urinary protein, and serological markers (ANA, anti-dsDNA). Imaging studies included echocardiography and high-resolution CT. Renal biopsy confirmed Class IV lupus nephritis. The patient received high-dose corticosteroids, hydroxychloroquine, and mycophenolate mofetil, with supportive management for pulmonary hypertension.
Results: The patient’s 24-hour proteinuria reduced from 4.2 g/day to 1.2 g/day. Pulmonary artery pressure improved from 35 mmHg to 30 mmHg after four weeks. Pleural effusions resolved completely, and renal function stabilized (creatinine from 1.9 mg/dL to 1.3 mg/dL).
Conclusion: This rare presentation of late-onset SLE in a male underscore the need for comprehensive evaluation and early intervention to prevent severe complications.

Article Details

How to Cite
Yahya Ur Rehman, Tanvi Yadav, Priya Yadav, & Sruthy Sasikumar. (2024). Unusual Case of Systemic Lupus Erythematosus (SLE) With Middle-Age Onset and Atypical Multisystem Involvement: Middle-Age Onset SLE With Multisystem Involvement. Journal of Health and Rehabilitation Research, 4(3), 1–5. https://doi.org/10.61919/jhrr.v4i3.1621
Section
Articles
Author Biographies

Tanvi Yadav, Northern State Medical University, Russia

As a co-author, I am writing to express my full support for the submission of this case report. I have contributed significantly to the data analysis and interpretation, and I approve the final manuscript for publication.

Priya Yadav, Pleven Medical University, Bulgaria

As a co-author, I am writing to express my full support for the submission of this case report. I have contributed significantly to the data analysis and interpretation, and I approve the final manuscript for publication.

Sruthy Sasikumar, Tbilisi State Medical University, Georgia

As a co-author, I am writing to express my full support for the submission of this case report. I have contributed significantly to the data analysis and interpretation, and I approve the final manuscript for publication.

References

Sontheimer RD. Lupus Erythematosus and the Skin. Journal of Investigative Dermatology. 2009;129(2):276-287.

Friedman A, Putterman C. Lupus Nephritis: A Review. American Journal of Kidney Diseases. 2017;69(5):688-694.

Moroni G, Raffiotta F, Ponticelli C. Management of Lupus Nephritis. Nature Reviews Nephrology. 2018;14(6):381-392.

Zhang Y, Zhang L, Wang Y, Zhang L. Lupus Pneumonitis: Clinical Features and Outcomes. BMC Pulmonary Medicine. 2017;17(1):57.

Drenkard C, Villa AR, Alarcón GS. Prevalence of Systemic Lupus Erythematosus in the United States: A Population-Based Study. Arthritis & Rheumatology. 2014;66(12):3545-3551.

Peterson AL, Ward MM, Fuentes AE, Malignancy P. The Impact of Lupus Nephritis on Outcomes in Systemic Lupus Erythematosus. Lupus Science & Medicine. 2015;2(1).

Hoffman R, Wilkinson M, Muller R. Pulmonary Hypertension in Systemic Lupus Erythematosus. Lupus. 2019;28(2):156-162.

McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, et al. Treatment of Pulmonary Arterial Hypertension. Journal of the American College of Cardiology. 2005;46(1):117-124.